Fig. 1From: Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer’s disease modelsExperimental protocol. Experiment A: treatment with tolfenamic acid on P12 rats for 4 h and 6 h; Experiment B: treatment with tolfenamic acid for 14 days, then perform the behavioral experimentsBack to article page